Squarepoint Ops LLC Sells 20,008 Shares of Xeris Pharmaceuticals, Inc. (NASDAQ:XERS)

Squarepoint Ops LLC lowered its holdings in Xeris Pharmaceuticals, Inc. (NASDAQ:XERS – Get Rating) by 61.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,595 shares of the company’s stock after selling 20,008 shares during the period. Squarepoint […]

Related Keywords

Canada ,Chicago ,Illinois ,United States ,Steven Prestrelski ,Wealth Strategies Group ,Xeris Pharmaceuticals Inc ,Xeris Pharmaceuticals ,Securities Exchange Commission ,Zacks Investment Research ,Quarter For Xeris Pharmaceuticals ,Xeris Biopharma Holdings Inc ,Nasdaq ,Ae Wealth Management ,Exchange Commission ,Squarepoint Ops ,Pricet Rowe Associates Inc ,Xeris Pharmaceuticals Profile Get Rating ,Royal Bank ,Get Rating ,Strategies Group ,Investment Research ,Pharmaceuticals Profile ,Biopharma Holdings ,Visit Holdingschannel ,Nasdaq Xers ,Sixers ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,